FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 6.123
AS - Asia 3.822
EU - Europa 1.750
SA - Sud America 608
AF - Africa 111
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.432
Nazione #
US - Stati Uniti d'America 5.966
SG - Singapore 1.354
CN - Cina 980
BR - Brasile 482
VN - Vietnam 445
DE - Germania 322
UA - Ucraina 317
HK - Hong Kong 308
IT - Italia 238
TR - Turchia 210
GB - Regno Unito 181
FI - Finlandia 161
BD - Bangladesh 115
FR - Francia 113
SE - Svezia 110
RU - Federazione Russa 100
JP - Giappone 95
IN - India 74
ID - Indonesia 71
MX - Messico 66
CA - Canada 64
PL - Polonia 48
ZA - Sudafrica 41
AR - Argentina 39
IQ - Iraq 29
AT - Austria 28
ES - Italia 28
NL - Olanda 25
VE - Venezuela 20
EC - Ecuador 19
PK - Pakistan 17
CZ - Repubblica Ceca 16
MA - Marocco 16
AU - Australia 15
LT - Lituania 15
KE - Kenya 14
SA - Arabia Saudita 14
CL - Cile 12
DZ - Algeria 12
PY - Paraguay 12
CO - Colombia 11
PH - Filippine 11
EG - Egitto 9
JM - Giamaica 9
KR - Corea 9
MY - Malesia 9
UZ - Uzbekistan 9
CH - Svizzera 8
JO - Giordania 8
BE - Belgio 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
AZ - Azerbaigian 5
IE - Irlanda 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
UY - Uruguay 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
TG - Togo 3
BG - Bulgaria 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NI - Nicaragua 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
Totale 12.423
Città #
Singapore 869
Ashburn 683
Fairfield 473
Woodbridge 437
San Jose 430
Santa Clara 329
Jacksonville 303
Hong Kong 301
Beijing 300
Houston 279
Chandler 267
Ann Arbor 189
Wilmington 176
Cambridge 172
Seattle 159
Los Angeles 157
Ho Chi Minh City 153
Izmir 131
New York 105
Council Bluffs 100
Nanjing 99
Hanoi 96
Princeton 92
Tokyo 92
Munich 83
Lauterbourg 79
Helsinki 75
Dallas 70
Buffalo 58
Jakarta 53
São Paulo 51
Mexico City 49
Milan 49
Shanghai 49
Warsaw 43
San Diego 38
Boardman 37
Addison 35
Hefei 35
Tianjin 35
Orem 33
Hebei 31
Nanchang 31
Da Nang 27
Turku 27
Changsha 25
Shenyang 25
Chennai 24
Denver 24
Jiaxing 24
Chicago 22
London 22
Bremen 21
Rio de Janeiro 21
Vienna 21
Dong Ket 20
Johannesburg 20
Montreal 20
Moscow 18
San Mateo 18
Brooklyn 17
Frankfurt am Main 17
Nuremberg 17
Toronto 17
Atlanta 16
Baghdad 16
Norwalk 16
Haiphong 15
Boston 14
Curitiba 14
Falkenstein 14
Phoenix 14
San Francisco 13
Washington 13
Brasília 12
Dearborn 12
Guangzhou 12
Nairobi 12
Poplar 12
Redwood City 11
Rome 11
Ankara 10
Belo Horizonte 10
Brno 10
Campinas 10
Ferrara 10
Hangzhou 10
Manchester 10
Ningbo 10
Philadelphia 10
Can Tho 9
Charlotte 9
Jinan 9
Krasnodar 9
Mountain View 9
Sydney 9
Taizhou 9
Dhaka 8
Falls Church 8
Jeddah 8
Totale 8.177
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 244
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 243
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 235
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 234
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 211
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 205
Enfisema polmonare: prospettive di terapia 200
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 200
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 197
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 196
Airway smooth muscle biochemistry and asthma 191
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 191
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 189
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 189
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 184
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 183
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 181
Helicobacter pylori and chronic bronchitis 180
Asthma progression and mortality: The role of inhaled corticosteroids 180
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 178
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 174
Inhaled corticosteroids in COPD: Friend or foe? 172
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 171
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 169
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 167
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 167
Anti-inflammatory treatments for asthma: Past, present, future 165
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 165
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 163
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 162
Altri problemi di patologia respiratoria 161
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 160
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 160
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 159
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 158
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 154
Blood eosinophils for the management of COPD patients? 153
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 152
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 152
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 151
Prevention of Chronic Obstructive Pulmonary Disease 144
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 144
Inhaled corticosteroid containing combinations and mortality in COPD 142
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 141
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 140
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 140
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 138
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 138
What can we learn from late-onset and occupational asthma? 138
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 137
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 136
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 131
Chronic cough in adults 131
Mechanism of occupational asthma 129
Neutrophils and asthma. 127
Severity of airflow limitation is associated with severity of airway inflammation in smokers 127
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 125
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 123
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 121
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 120
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 120
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 119
Management of chronic refractory cough in adults 119
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 118
Glucocorticoidi 115
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 115
Neutrophils and Asthma 113
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 112
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 111
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 111
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 106
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 105
A person-centred clinical approach to the multimorbid patient with COPD 104
HLA class II molecules and asthma induced by toleune diisocyanate 103
Evaluation by self-monitoring and noninvasive measures 101
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 101
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 100
Small airway dysfunction: not so silent after all? 96
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 90
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 87
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 74
Rate of Decline of FEV1 as Biomarker of Survival? 72
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 69
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 68
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 68
null 50
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort 49
null 45
Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS 13
The ROME COPD exacerbation proposal works! Time to move forward 8
Totale 12.580
Categoria #
all - tutte 60.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.779
Totale 62.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 0 0 125
2021/2022797 28 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20265.392 568 223 437 662 784 358 645 286 538 562 275 54
Totale 12.580